Pfizer, along with rival drug companies Merck & Co. and Roche Holding AG, have been racing to create an easy-to-administer antiviral pill for the coronavirus

Pfizer, along with rival drug companies Merck & Co. and Roche Holding AG, have been racing to create an easy-to-administer antiviral pill for the coronavirus